Literature DB >> 25869593

Extract from Phyllanthus urinaria L. inhibits hepatitis B virus replication and expression in hepatitis B virus transfection model in vitro.

Ying Wu1, Ying Lu2, Shu-yu Li2, Yue-han Song2, Yu Hao2, Qian Wang2.   

Abstract

OBJECTIVE: To explore the effects of the extract from Phyllanthus urinaria L. on hepatitis B virus (HBV) replication and expression in HBV transient transfection model in vitro.
METHODS: The eukaryotic expression plasmid pHBV1.1, which contains 1.1-fold-overlength genome of HBV, was transfected into the human hepatoma cell line, HepG2, to establish and assess the HBV transient transfection model. The extract from Phyllanthus urinaria L. was prepared in different concentrations and methyl thiazolyl tetrazolium was used to detect the maximum nontoxic concentration of the drug. The extract from Phyllanthus urinaria L. were added into the transfected cell, at the concentrations of 0.8, 0.2 and 0.05 g/L, respectively. Four days after drug application, enzyme-linked immuno sorbent assay was used to detect the concentration of HBsAg in the supernatants, Southern blot was applied to analyze HBV DNA level, and Western blot was used to detect the expression of HBcAg in cells.
RESULTS: After the transfection of plasmid pHBV1.1 into HepG2 cells, the concentration of HBsAg in supernatants was increased obviously as compared with that of the normal cells (P<0.05), and all expected HBV replicative intermediates were confirmed by Southern blot analysis, which ensured the successful establishment of the HBV transient transfection model. After the application of drugs at the concentrations of 0.8 and 0.2 g/L, the level of HBsAg was obviously decreased in the supernatants, as compared with that of the virus group (P<0.05); Southern blot showed that the level of HBV rc DNA, ds DNA, ss DNA was obviously reduced compared with that of the virus group (P<0.01); Western blot revealed that the expression of HBcAg in the drug group was obviously inhibited, as compared with that of the virus group (P<0.01).
CONCLUSIONS: The extract from Phyllanthus urinaria L. obviously inhibited replication and expression of HBV in HBV transfected cell lines in vitro, thus exerting distinctive anti-HBV effects.

Entities:  

Keywords:  Chinese medicine; Phyllanthus urinaria L.; expression; hepatitis B virus; replication; transient transfection model

Mesh:

Substances:

Year:  2015        PMID: 25869593     DOI: 10.1007/s11655-015-2076-7

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  15 in total

1.  [Construction of recombinant eukaryotic expression plasmid containing 1.3-fold-overlength genome of HBV and its expression in HepG2 cells].

Authors:  Ni Tang; Ai-long Huang; Bing-qiang Zhang; Ge Yan; Ming-que Xiang; Dan Pu; Hui Guo
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2003-08

Review 2.  Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B.

Authors:  G L-H Wong; V W-S Wong; H L-Y Chan
Journal:  J Viral Hepat       Date:  2014-12       Impact factor: 3.728

3.  Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.

Authors:  M F Sprinzl; H Oberwinkler; H Schaller; U Protzer
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion.

Authors:  Anne Marie Dougherty; Haitao Guo; Gael Westby; Yuanjie Liu; Ender Simsek; Ju-Tao Guo; Anand Mehta; Pamela Norton; Baohua Gu; Timothy Block; Andrea Cuconati
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

5.  Efficacy of 3 years of adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance.

Authors:  Min-Ning Song; Mei-Zhu Hong; Dan-Qing Luo; Wen-Qi Huang; Feng Min; Rong-Hua Fan; Wei-Bing Wu; Li Zhang
Journal:  World J Hepatol       Date:  2012-12-27

Review 6.  Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection.

Authors:  F H Qi; Z X Wang; P P Cai; L Zhao; J J Gao; N Kokudo; A Y Li; J Q Han; W Tang
Journal:  Drug Discov Ther       Date:  2013-12

7.  [Studies on chemical constituents of Phyllanthus urinaria L].

Authors:  L Z Zhang; Y J Guo; G Z Tu; W B Guo; F Miao
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2000-10

8.  Beneficial therapeutic effect of Chinese herbal Bushen formula on CHB patients with mildly elevated alanine aminotransferase by down-regulating CD4+CD25+T cells.

Authors:  Man Li; Xue-Hua Sun; Zhen-Hua Zhou; Zhuo Yu; Shu-Gen Jin; Xiao-Jun Zhu; Yue-Qiu Gao
Journal:  J Ethnopharmacol       Date:  2013-02-07       Impact factor: 4.360

9.  Effectiveness of entecavir treatment and predictive factors for virologic response.

Authors:  Carmen Monica Preda; Cristian Baicus; Lucian Negreanu; Letitia Tugui; Sandra Viviana Olariu; Adriana Andrei; Ileana Zambatu; Mircea Mihai Diculescu
Journal:  Rev Esp Enferm Dig       Date:  2014-05       Impact factor: 2.086

Review 10.  Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review.

Authors:  Lingyi Zhang; Guqi Wang; Weihong Hou; Ping Li; Andrea Dulin; Herbert L Bonkovsky
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

View more
  5 in total

1.  Hepatoprotective Effects of Corilagin Following Hemorrhagic Shock are Through Akt-Dependent Pathway.

Authors:  Fu-Chao Liu; Irshad H Chaudry; Huang-Ping Yu
Journal:  Shock       Date:  2017-03       Impact factor: 3.454

2.  A Review of the Phytochemistry and Pharmacology of Phyllanthus urinaria L.

Authors:  Madamanchi Geethangili; Shih-Torng Ding
Journal:  Front Pharmacol       Date:  2018-10-01       Impact factor: 5.810

3.  Extracts of Qizhu decoction inhibit hepatitis and hepatocellular carcinoma in vitro and in C57BL/6 mice by suppressing NF-κB signaling.

Authors:  Ling-Feng Wan; Jian-Jiang Shen; Yao-Hui Wang; Wei Zhao; Nan-Yuan Fang; Xin Yuan; Bo-Yu Xue
Journal:  Sci Rep       Date:  2019-02-05       Impact factor: 4.379

4.  Huangjia Ruangan Granule Inhibits Inflammation in a Rat Model with Liver Fibrosis by Regulating TNF/MAPK and NF-κB Signaling Pathways.

Authors:  Qiang Cai; Zongquan Wang; Rong Zhang; Lili Zhang; Sainan Cui; Huiyuan Lin; Xinran Tang; Dongying Yang; Xianrong Lin; Shasha Bai; Jin Gao; Lei Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-30       Impact factor: 2.650

5.  Efficacy of a Chinese herbal formula on hepatitis B e antigen-positive chronic hepatitis B patients.

Authors:  Yu-Feng Xing; Chun-Shan Wei; Tian-Ran Zhou; Dan-Ping Huang; Wei-Chao Zhong; Bin Chen; Hua Jin; Xiao-Yu Hu; Zhi-Yun Yang; Qing He; Kai-Ping Jiang; Jun-Min Jiang; Zhen-Bin Hu; Xin Deng; Fan Yang; Feng-Yi Li; Gang Zhao; Li-Chun Wang; Yu-Qiang Mi; Zuo-Jiong Gong; Peng Guo; Jian-Hua Wu; Wei-Qun Shi; Hong-Zhi Yang; Da-Qiao Zhou; Guang-Dong Tong
Journal:  World J Gastroenterol       Date:  2020-08-14       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.